Survival of AIDS patients wth cryptosporidiosis

Infectious Diseases in Clinical Practice

Volumn 7, Issue 3, 1998, Pages 157-160

  Valdez, Hernan ^a   Burke, Don ^a   Gordon, Steve M ^b   Adal, Karim A ^b   Johnson, Joan H ^c   Wiest, Peter M ^c  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c METROHEALTH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; FEMALE; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; SURVIVAL; TEACHING HOSPITAL;

EID: 0031924866     PISSN: 10569103     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019048-199803001-00008     Document Type: Article

References (16)

1. McGowan I. Hawkins AS, Weller IVD. The natural history of cryptosporidial diarrhoea in HIV-infected patients. AIDS 1993;7:349-54.
2. Blanshard C, Jackson AM. Shanson DC. et al. Cryptosporidiosis in HIV-seropositive patients. QJ Med 1992; 85 813-23.
3. Flanigan T, Whalen C, Turner J, et al. Cryptosporidium infection and CD4 counts Ann Intern Med 1992;116: 840-2.
4. Colford JM, Tager IB, Hirozawa AM. et al. Cryptosporidiosis among patients infected with human immunodeficiency virus: factors related to symptomatic infection and survival. AmJ Epidemiol 1996,144:807-19.
5. Vakil NB, Schwartz SM, Buggy BP, et al. Biliary cryptosporidiosis in HIV-infected people after the waterborne outbreak of cryptosporidiosis in Milwaukee. N Engl J Med 1996,334:19-23.
6. + T cell subset phenotyping independently predict survival time in patients infected with human immunodeficiency virus. J Infect Dis 1995:172:79-87.
7. Goodgame RW, Kimball K, Ching-Nan O, et al. Intestinal function and injury in acquired immunodeficiency syndrome-related cryptosporidiosis. Gastroenterology 1995; 108:1075-82.
8. Kotler DP, Francisco A, Clayton F, et al. Small intestinal injury and parasitic diseases in AIDS. Ann Intern Med 1990;113:444-9.
9. Suttmann U, Ockenga J, Selberg O, et al. Incidence and prognostic value of malnutrition and wasting in human immunodeficiency virus-infected outpatients. J Acquir Immune Defic Syndr 1995;8:239-46.
10. Kotler DP, Tiernet AR. Wang J, et al. Magnitude of body-cell-mass depletion and the timing of death from wasting in AIDS. Am J Clin Nutr 1989;50:444-7.
11. Whalen C, Horsburgh RC, Hom D, et al. Accelerated course of human immunodeficiency virus infection after tuberculosis. AmJ Respir Crit Care Med 1995;151.129-35.
12. Bentwich Z, Kalinkovich A, Weisman Z. Immune activation is a dominant factor in the pathogenesis of African AIDS. Immunol Today 1995;16:187-91.
13. White AC, Chappell CL, Hayat CS, et al. Paromomycin for cryptosporidiosis in AIDS. a prospective, double-blind trial. J Infect Dis 1994;170:419-24.
14. Hewitt RG, Yiannoutsos CT, Carey J, et al. A doubleblind, placebo-controlled trial of paromomycin for the treatment of cryptosporidiosis in patients with advanced HIV disease and CD4 counts under 150 (ACTG 192). Presented at the 4th Conference of Retroviruses and Opportunistic Infections: 1997; Jan 22-26; Washington (DC); 1997.
15. Glesby MJ, Hoover DL. Survival treatment selection bias in observational studies: examples from the AIDS literature. Ann Intern Med 1996;124:999-1005.
16. Lubeck DP, Bennett CL, Mazonson PD. et al. Quality of life and health service use among HIV-infected patients with chronic diarrhea. J Acquir Immune Defic Syndr 1993;6.478-84.